Format

Send to

Choose Destination
Neuropharmacology. 2009 Oct-Nov;57(5-6):481-95. doi: 10.1016/j.neuropharm.2009.07.027. Epub 2009 Jul 23.

GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders.

Author information

1
Wyeth Research, Neuroscience Discovery, Princeton NJ 08852, USA. charyce@wyeth.com

Abstract

Gamma-aminobutyric acid type A (GABA(A)) receptors play an important role in mediating fast synaptic inhibition in the brain. They are ubiquitously expressed in the CNS and also represent a major site of action for clinically relevant drugs. Recent technological advances have greatly clarified the molecular and cellular roles played by distinct GABA(A) receptor subunit classes and isoforms in normal brain function. At the same time, postmortem and genetic studies have linked neuropsychiatric disorders including schizophrenia and bipolar disorder with GABAergic neurotransmission and various specific GABA(A) receptor subunits, while evidence implicating GABA(A)R-associated proteins is beginning to emerge. In this review we discuss the mounting genetic, molecular, and cellular evidence pointing toward a role for GABA(A) receptor heterogeneity in both schizophrenia etiology and therapeutic development. Finally, we speculate on the relationship between schizophrenia-related disorders and selected GABA(A) receptor associated proteins, key regulators of GABA(A) receptor trafficking, targeting, clustering, and anchoring that often carry out these functions in a subtype-specific manner.

PMID:
19631671
PMCID:
PMC2836902
DOI:
10.1016/j.neuropharm.2009.07.027
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center